Argonaute RNA

Bristol, United Kingdom

Argonaute RNA company research projects build on existing intellectual property.

$2.3M raised

Jul 2024

Venture - Series Unknown

Biotechnology

Top Investors

Development Bank of Wales Empirical Ventures The Fink Family Office Bristol Private Equity Club

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Argonaute RNA

How much funding has Argonaute RNA raised?

Argonaute RNA has raised $2.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.

Who are Argonaute RNA's investors?

Argonaute RNA's investors include Development Bank of Wales, Empirical Ventures, The Fink Family Office, Bristol Private Equity Club.

Where is Argonaute RNA headquartered?

Argonaute RNA is headquartered in Bristol, United Kingdom.

What does Argonaute RNA do?

Argonaute RNA company research projects build on existing intellectual property.

What stage is Argonaute RNA at?

Argonaute RNA is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 17, 2024.

MLA

"Argonaute RNA — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/argonaute-rna. Accessed July 2, 2026.

APA

VCBacked. (2024). Argonaute RNA — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/argonaute-rna

Wikipedia (cite web)

{{cite web |title=Argonaute RNA — Funding & Investors |url=https://www.vcbacked.co/company/argonaute-rna |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 17, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K